Screener
Globus Medical GMED Musculoskeletal Solutions — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Globus Medical’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054450
| (In thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Musculoskeletal Solutions | $763,540 | $710,182 | $1,496,524 | $1,286,115 |
| Enabling Technologies | 26,072 | 35,160 | 52,942 | 57,348 |
| Total net sales | $789,612 | $745,342 | $1,549,466 | $1,343,463 |
Item 1. Financial Statements
FAQ
- What is Globus Medical's musculoskeletal solutions — net sales?
- Globus Medical (GMED) reported musculoskeletal solutions — net sales of $763.54M in Q2 2026.
- How has Globus Medical's musculoskeletal solutions — net sales changed year-over-year?
- Globus Medical's musculoskeletal solutions — net sales increased by 7.5% year-over-year, from $710.18M to $763.54M.
- What does musculoskeletal solutions — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices, implants, and surgical instruments specifically designed for spinal and orthopedic procedures. It reflects the core commercial performance of the company's primary product portfolio, excluding advanced robotic or enabling technologies. Growth in this segment indicates successful market penetration and adoption of the company's traditional surgical hardware solutions among hospitals and orthopedic surgeons.
Ask your AI about Globus Medical's musculoskeletal solutions — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude